Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Health insurance giant Aetna, which is owned by CVS Health, is launching fully insured and self-insured healthcare network options through Aetna Whole Health Atlanta.
A machine learning-powered smartphone application could help patients with a chronic cough document their symptoms over an extended period of time, according to new findings published in Digital Biomarkers.
An AI-powered wearable sensor can detect changes in heart failure patients before an actual crisis occurs, according to new findings published in Circulation: Heart Failure.
As AI continues to make a profound impact on the medical imaging industry, the FDA is hosting a two-day public workshop to discuss the benefits and risks of this powerful technology.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
